Improve the perioperative process – more personalization means fewer adverse drug reactions and the potential for less reliance on post-operative opioids.
Enhance pain management throughout the entire operative process by embracing a personalized approach.
Through pharmacogenetics testing, providers now have the tools and resources to reduce adverse drug reactions and lower dependency on post-operative opioids.
Our solutions ensure providers have truly personalized options for optimized recovery for their patients.
Using targeted genetic markers and a patient’s unique information (i.e., demographic information and clinical history), the PrecisionOp platform offers a customized solution. We provide personalized recommendations with opioid-sparing options, promoting post-surgical recovery, and increasing patient satisfaction.
Of the estimated 80 million surgeries performed annually, complications from prescription mismanagement for postoperative pain contribute to ADRs, prolonged hospital stay, readmissions, and overuse of opioids.1
20% of patients experience adverse events within three weeks of discharge.3
180 million surgeries performed annually, complications from prescription mismanagement for postoperative pain contribute to ADRs, prolonged hospital stay, readmissions, and overuse of opioids (citation: Koepke EJ, Manning EL, Miller TE, Ganesh A, Williams DGA, Manning MW. The rising tide of opioid use and abuse: the role of the anesthesiologist. Perioper Med. 2018;7(1):1-10. doi:10.1186/s13741-018-0097-4)
2$528 billion estimated to be spent annually in the United States on drug-related morbidity and mortality resulting from nonoptimized medication therapy (citation: Watanabe JH, McInnis T, Hirsch JD. Cost of Prescription Drug-Related Morbidity and Mortality. Ann Pharmacother. 2018;52(9):829-837. doi:10.1177/1060028018765159)
320% of patients experience adverse events within three weeks of discharge, with adverse drug reactions accounting for nearly two thirds of such events (citation: Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138(3):161-167. doi:10.7326/0003-4819-138-3-200302040-00007)
4Adverse drug reactions have been estimated to be as high as the 4th leading cause of death in the United States and represent a leading clinical issue in the perioperative arena (citation: Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205. doi:10.1001/jama.279.15.1200)